These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 38732545)

  • 1. Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review.
    Moukham H; Lambiase A; Barone GD; Tripodi F; Coccetti P
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
    Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents.
    Viegas FPD; Gontijo VS; de Freitas Silva M; Ortiz CJC; Dos Reis Rosa Franco G; Ernesto JT; Damasio CM; Silva IMF; Campos TG; Viegas C
    Curr Neuropharmacol; 2022; 20(7):1297-1328. PubMed ID: 34825873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
    Liu S; Li X
    Adv Exp Med Biol; 2020; 1207():725-730. PubMed ID: 32671789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases.
    Maiti P; Dunbar GL
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Therapeutic Potential of Phytoconstituents for Addressing Neurodegenerative Disorders.
    Kamboj S; Sharma P; Kamboj R; Kamboj S; Hariom ; Girija ; Guarve K; Dutt R; Verma I; Dua K; Rani N
    Cent Nerv Syst Agents Med Chem; 2024; 24(2):129-144. PubMed ID: 38265386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective properties of resveratrol in different neurodegenerative disorders.
    Albani D; Polito L; Signorini A; Forloni G
    Biofactors; 2010; 36(5):370-6. PubMed ID: 20848560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of mushrooms and their biomolecules along with a glimpse of in silico approach in neurodegenerative diseases.
    Rai SN; Mishra D; Singh P; Vamanu E; Singh MP
    Biomed Pharmacother; 2021 May; 137():111377. PubMed ID: 33601145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases.
    Mohd Sairazi NS; Sirajudeen KNS
    Evid Based Complement Alternat Med; 2020; 2020():6565396. PubMed ID: 32148547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of neuroprotective action of natural compounds.
    Wąsik A; Antkiewicz-Michaluk L
    Pharmacol Rep; 2017 Oct; 69(5):851-860. PubMed ID: 28623709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review.
    Klose J; Griehl C; Roßner S; Schilling S
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases.
    Bandiwadekar A; Jose J; Khayatkashani M; Habtemariam S; Khayat Kashani HR; Nabavi SM
    J Mol Neurosci; 2022 Mar; 72(3):653-676. PubMed ID: 34697770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol: new avenues for a natural compound in neuroprotection.
    Pallàs M; Porquet D; Vicente A; Sanfeliu C
    Curr Pharm Des; 2013; 19(38):6726-31. PubMed ID: 23530512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways.
    Phukan BC; Roy R; Gahatraj I; Bhattacharya P; Borah A
    Phytother Res; 2023 Dec; 37(12):5657-5699. PubMed ID: 37823581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.
    Ayaz M; Mosa OF; Nawaz A; Hamdoon AAE; Elkhalifa MEM; Sadiq A; Ullah F; Ahmed A; Kabra A; Khan H; Murthy HCA
    Phytomedicine; 2024 Feb; 124():155272. PubMed ID: 38181530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice.
    Giacomeli R; Izoton JC; Dos Santos RB; Boeira SP; Jesse CR; Haas SE
    Brain Res; 2019 Oct; 1721():146325. PubMed ID: 31325424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mushroom-Derived Medicine? Preclinical Studies Suggest Potential Benefits of Ergothioneine for Cardiometabolic Health.
    Lam-Sidun D; Peters KM; Borradaile NM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin and neurodegenerative diseases: a perspective.
    Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.
    Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.